Author

Sahil Khanna 1

1 Mayo Clinic,Rochester,United States

A NON-FROZEN, LYOPHILIZED, ORAL MICROBIOTA-BASED DRUG RBX7455 IS SAFE, REDUCES CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE, AND RESTORES THE MICROBIOME: CLINICAL EVIDENCE FROM 3 PATIENT COHORTS

Sahil Khanna, Darrell Pardi, Dale Gerding, Ken Blount, Courtney Jones, Bill Shannon, Elena Deych

A SUBSET OF PATIENTS WITH NON-INFECTIOUS DIARRHEA HAVE ALTERED GUT MICROBIOTA SIMILAR TO C. DIFFICILE INFECTION

Vanessa Hale, Jun Chen, Vayu Rekdal, Brad Schmidt, Sahil Khanna, Patricio Jeraldo, Charles David Enriquez-Sarano, Darrell Pardi, Madhusudan Grover, Heidi Nelson, Nicholas Chia, Gianrico Farrugia, Purna Kashyap

AN INVESTIGATIONAL ORAL MICROBIOME DRUG, CP101, FOR THE PREVENTION OF RECURRENT C. DIFFICILE INFECTION: A RANDOMIZED, PLACEBO-CONTROLLED, MULTI-CENTER TRIAL (PRISM3)

Jessica Allegretti, Colleen R. Kelly, Thomas Louie, Monika Fisher, Susy Hota, Bharat Misra, Nicholas W Van Hise, Eugene Yen, Jeff S Bullock, John Pullman, Michael Silverman, Ian Davis, Sarah McGill, Shrish Budree, Sahil Khanna, Darrell Pardi, Robert Orenstein, Ari Grinspan, Najwa El-Nachef, Colleen Kraft, Thomas J. Boro

EPIDEMIOLOGY OF POST INFECTIOUS IRRITABLE BOWEL SYNDROME FOLLOWING CLOSTRIDIUM DIFFICILE INFECTION

Firas AlNahhas, Akhilesh Wadhwa, Sahil Khanna, Purna Kashyap, Darell Pardi, Ross Dierkhising, Madhusudan Grover

Microbiota restoration therapeutic candidates for preventing recurrent Clostridium difficile infections: Similar 6-month outcomes for enema-administered RBX2660 and oral capsule-administered RBX7455

Ken Blount, Sahil Khanna, Darrell Pardi, Courtney Jones, Sarah Mische, Bill Shannon, Elena Deych

RBX2660, A MICROBIOTA-BASED DRUG FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION, IS SAFE AND EFFECTIVE: RESULTS FROM A RANDOMISED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL 

Robert Orenstein, Erik Dubberke, Christine H Lee, Sahil Khanna, Gail Hecht

Item 1 - 6 / 6
1